- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02738034
Cogmed Training Effect in Hypertensive Patients With Cognitive Impairment
November 16, 2021 updated by: Regina Silva Paradela, University of Sao Paulo General Hospital
Cogmed Training Effect in Hypertensive Patients With Cognitive Impairment: a Randomized Clinical Trial
Systemic arterial hypertension is a disease with high prevalence in several countries, including Brazil.
Many studies have correlated hypertension with accelerated loss of cognitive function, especially executive functions.
There is some evidence that working memory (WM) is compromised in these populations.
However, some computerized training has been developed to rehabilitate the WM, and among them the investigators highlight the Cogmed.
Thus, the aim of this study is to evaluate the effects of Cogmed training in the performance of WM and attention of hypertensive patients, as well as the impact of training in the structure and brain function.
Study Overview
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Sao Paulo, São Paulo, Brazil, 05403-900
- Regina Silva Paradela
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individuals of both genders, of any ethnicity
- Signing the consent form
- Access to computer with internet at home
- Inexperienced to computerized cognitive training
- Hypertensive pre-diagnosed
- Basic schooling of four years
- Cognitive impairment
Exclusion Criteria:
- Marked functional limitation
- Cognitive limitation or serious communication
- Severe neurological and psychiatric diseases
- Stroke history, head trauma or substance abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adaptive training group
The intervention group will be composed of hypertensive participants with cognitive decline that will be submitted to the training program (Cogmed) for approximately 10 weeks.
Across training, task difficulty was adjusted as a function of individual performance.
|
The Cogmed is computer software designed to train visuospatial and audio-verbal working memory, and other functions associated with working memory: attention, focus and impulsiveness.
It has three versions adapted to different age groups: Cogmed for younger children, about 4-7 years, which are not yet so familiar with numbers and letters; Cogmed for children over 7 years and adolescents; and Cogmed for youth and adults over 18 years.
In this study we will use the version for youth and adults over 18 years.
|
|
Active Comparator: Active control Group
In the control group, hypertensive patient will be submitted to a set of online games available on the internet and previously determined.
In this way, the control group will receive the same motivation, as well as will be engaged in computerized activities, in the same way as the experimental group.
The difference is that these varied games do not provide any type of intense and adaptive training, at the same time as they do not stimulate any specific cognitive function.
|
The Cogmed is computer software designed to train visuospatial and audio-verbal working memory, and other functions associated with working memory: attention, focus and impulsiveness.
It has three versions adapted to different age groups: Cogmed for younger children, about 4-7 years, which are not yet so familiar with numbers and letters; Cogmed for children over 7 years and adolescents; and Cogmed for youth and adults over 18 years.
In this study we will use the version for youth and adults over 18 years.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Working memory score
Time Frame: 10 weeks
|
Backward Digits Test / Letter-Number Sequencing (WAIS-III): total score (sum of right answers)
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain function
Time Frame: 10 weeks
|
Functional magnetic resonance
|
10 weeks
|
|
Executive functions score
Time Frame: 10 weeks
|
Stroop test, Wisconsin Card Sorting Test, Frontal Assessment Battery and Controlled Oral Word Association Test
|
10 weeks
|
|
Verbal memory score
Time Frame: 10 weeks
|
Stories of Wechsler Memory Scale Revised - WMS R
|
10 weeks
|
|
Visual memory score
Time Frame: 10 weeks
|
Rey complex figure
|
10 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medication adherence score
Time Frame: 10 weeks
|
Short version of Morinsk Questionnaire
|
10 weeks
|
|
Quality of life score
Time Frame: 10 weeks
|
Whoqol
|
10 weeks
|
|
Perceived Stress score
Time Frame: 10 weeks
|
PSS14
|
10 weeks
|
|
Anxiety and Depression symptoms score
Time Frame: 10 weeks
|
BAI and BDI questionnaires
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
October 1, 2020
Study Completion (Actual)
December 1, 2020
Study Registration Dates
First Submitted
March 23, 2016
First Submitted That Met QC Criteria
April 13, 2016
First Posted (Estimate)
April 14, 2016
Study Record Updates
Last Update Posted (Actual)
November 17, 2021
Last Update Submitted That Met QC Criteria
November 16, 2021
Last Verified
November 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CogDoc2016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Cogmed
-
Duke UniversityCompletedCognitive Impairment | Sickle Cell DiseaseUnited States
-
Indiana UniversityCompletedBilateral Hearing LossUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixBarrow Neurological Institute; Barrow Neurological FoundationRecruitingMild Cognitive Impairment (MCI)United States
-
University of HawaiiNational Institute on Drug Abuse (NIDA); University of Maryland, BaltimoreUnknown
-
KU LeuvenActive, not recruitingCerebral PalsyBelgium
-
University of California, DavisCompletedADHD | AttentionUnited States
-
Children's National Research InstituteRecruitingSickle Cell DiseaseUnited States
-
Kessler FoundationCompleted
-
University of TorontoUnknownAttention Deficit DisorderCanada
-
Assistance Publique - Hôpitaux de ParisCompletedAttention Deficit Hyperactivity Disorder (ADHD)France